Haematopoietic cell-fate decisions, chromatin regulation and ikaros

Nature Reviews. Immunology
Katia Georgopoulos

Abstract

The regulated production of several terminally differentiated cell types of the blood and immune systems (haematopoiesis) has been the focus of many studies on cell-fate determination. Chromatin and the control of its structure have been implicated in the regulation of cell-fate decisions and in the maintenance of the determined states. Here, I review advances in the field, emphasizing the potential role of chromatin in lineage commitment and differentiation. In this context, I discuss Ikaros, an essential regulator of lymphocyte development and an integral component of a functionally diverse chromatin remodelling network that operates from the early stages of haematopoiesis to the mature lymphocytes.

References

Jul 1, 1988·Science·G J SpangrudeI L Weissman
Mar 1, 1995·Molecular and Cellular Biology·C C Adams, J L Workman
Dec 1, 1994·Molecular and Cellular Biology·A Molnár, K Georgopoulos
Jan 1, 1996·Biology of the Neonate·C S AbrahámD Molnár
Jan 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·C A KlugI L Weissman
Apr 16, 1998·Genes & Development·K Struhl
Jun 4, 1998·Current Opinion in Genetics & Development·K Luger, T J Richmond
Nov 7, 1998·Immunity·J H WangK Georgopoulos
Mar 11, 1999·Current Opinion in Genetics & Development·T Kouzarides
Jun 5, 1999·The EMBO Journal·J KoipallyK Georgopoulos
Jul 15, 1999·Nature Structural Biology·F Winston, C D Allis
Sep 29, 1999·Genes & Development·R E Kingston, G J Narlikar
Sep 29, 1999·Genes & Development·N YudkovskyC L Peterson
Oct 19, 1999·The Journal of Experimental Medicine·S WinandyK Georgopoulos
Nov 2, 1999·The Journal of Experimental Medicine·A NichogiannopoulouK Georgopoulos
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·B D StrahlC D Allis

❮ Previous
Next ❯

Citations

Nov 8, 2011·Basic Research in Cardiology·Diederik W D KusterDirk J Duncker
Nov 6, 2013·Current Hematologic Malignancy Reports·Nicole C C Them, Robert Kralovics
Nov 27, 2008·Cell Biochemistry and Biophysics·John F TremlMichael P Cancro
Sep 4, 2013·International Journal of Hematology·Takafumi YokotaYuzuru Kanakura
Nov 26, 2002·Journal of Immunological Methods·Elli VeistinenOlli Lassila
Dec 14, 2002·Trends in Biotechnology·Thomas Werner
Mar 5, 2003·Medical Hypotheses·Stanislaw R Burzynski
Jul 20, 2002·The International Journal of Biochemistry & Cell Biology·Belinda J WestmanDavid Gell
Oct 31, 2003·Clinical Immunology : the Official Journal of the Clinical Immunology Society·David R Fitzpatrick, Christopher B Wilson
Aug 27, 2010·Leukemia·J R Collins-Underwood, C G Mullighan
Jul 4, 2012·Nature Immunology·Francisco J QuintanaVijay K Kuchroo
Sep 10, 2013·Nature Immunology·Hilde SchjervenStephen T Smale
Dec 28, 2004·Nature Immunology·Maya GoldmitYehudit Bergman
Jun 21, 2007·Nature Immunology·Michael S Krangel
Oct 21, 2004·Nature Neuroscience·Jianxin BaoRichard T Ambron
Mar 16, 2007·Genes and Immunity·P J ChildressN B Perumal
Jan 11, 2007·Immunology and Cell Biology·Amanda M de MestreMark D Hulett
May 20, 2003·Immunology and Cell Biology·Angelita Rebollo, Christian Schmitt
Jan 1, 2009·Médecine sciences : M/S·Marilyne DijonCécile Tonnelle
Jan 10, 2009·The New England Journal of Medicine·Katia Georgopoulos
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Eric T ClambeyPhilippa Marrack
Mar 3, 2010·Proceedings of the National Academy of Sciences of the United States of America·Monique DailKevin Shannon
Nov 20, 2009·The Journal of Biological Chemistry·Rajan M ThomasAndrew D Wells
Feb 9, 2010·The Journal of Biological Chemistry·Shuyang YuHai-Hui Xue
May 29, 2007·The Journal of Biological Chemistry·Xiaowei LiuFred Schaufele
Dec 17, 2003·The Journal of Experimental Medicine·Thomas C GebuhrTerry Magnuson
Jun 24, 2004·The Journal of Experimental Medicine·Christopher S SeetBarbara L Kee
Dec 8, 2004·The Journal of Experimental Medicine·Matthias MerkenschlagerKaren E Brown
Jul 23, 2004·Cloning and Stem Cells·Vincent QuivyCarine Van Lint
Dec 7, 2011·Stem Cells and Development·Raquel Martín-IbáñezJosep M Canals
Dec 5, 2002·Genes & Development·Sinisa DovatStephen T Smale
Aug 4, 2007·Science·Dimitris Kioussis, Katia Georgopoulos
Jun 23, 2010·Molecular and Cellular Biology·Shibin MaRunqing Lu
Dec 31, 2008·Molecular and Cellular Biology·Stefania BottardiEric Milot
Mar 17, 2004·Molecular and Cellular Biology·Pablo Gómez-del ArcoKatia Georgopoulos
Aug 2, 2005·Molecular and Cellular Biology·Shaun M CowleyRobert N Eisenman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.